These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12868305)

  • 1. [Diabetes and genetic and acquired lipodystrophy syndrome].
    Capeau J; Magré J; Vigouroux C; Caron M; Maachi M; Dubosclard E; Lascols O; Bastard JP
    Journ Annu Diabetol Hotel Dieu; 2003; ():99-109. PubMed ID: 12868305
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of fat redistribution, insulin resistance and hepatic fatty infiltration in HIV-associated lipodystrophy syndrome by pioglitazone: a case report.
    Prasithsirikul W; Bunnag P
    J Med Assoc Thai; 2004 Feb; 87(2):166-72. PubMed ID: 15061300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipodystrophies and the metabolic syndrome.
    Heymann WR
    J Am Acad Dermatol; 2008 Nov; 59(5):887-8. PubMed ID: 19119102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue].
    Capeau J; Vigouroux C; Magré J; Lascols O; Caron M; Bastard JP
    C R Biol; 2006 Aug; 329(8):639-52; discussion 653-5. PubMed ID: 16860281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and HIV associated lipodystrophy.
    Barbaro G
    Med Sci Monit; 2003 Nov; 9(11):LE26. PubMed ID: 14586285
    [No Abstract]   [Full Text] [Related]  

  • 7. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
    Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
    Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome.
    Grinspoon S
    Clin Infect Dis; 2003; 37 Suppl 2():S85-90. PubMed ID: 12942379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
    Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of lipodystrophy in Thai-HIV infected patients.
    Puttawong S; Prasithsirikul W; Vadcharavivad S
    J Med Assoc Thai; 2004 Jun; 87(6):605-11. PubMed ID: 15279336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control and treatment of HIV-associated lipodystrophy syndrome and related metabolic complications].
    Hansen BR; Haugaard SB; Nielsen JO; Madsbad S; Iversen J; Andersen O
    Ugeskr Laeger; 2003 Oct; 165(44):4218-20. PubMed ID: 14621554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin resistance and adipose tissue gene expression in humans].
    Bastard JP
    Ann Biol Clin (Paris); 2004; 62(1):25-31. PubMed ID: 15047487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease.
    Behrens GM; Meyer-Olson D; Stoll M; Schmidt RE
    AIDS; 2003 Apr; 17 Suppl 1():S149-54. PubMed ID: 12870541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipodystrophies].
    Fardet L; Vigouroux C; Capeau J
    Rev Med Interne; 2013 Oct; 34(10):614-22. PubMed ID: 23287278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-associated lipodystrophy syndrome. Diagnosis, prevalence, pathogenesis and metabolic complications].
    Haugaard SB; Hansen BR; Madsbad S; Iversen J; Nielsen JO; Andersen O
    Ugeskr Laeger; 2003 Oct; 165(44):4215-8. PubMed ID: 14621553
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
    Johnson JA; Albu JB; Engelson ES; Fried SK; Inada Y; Ionescu G; Kotler DP
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E261-71. PubMed ID: 14532165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression.
    Bhasin S
    Clin Infect Dis; 2003; 37 Suppl 2():S142-9. PubMed ID: 12942389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.